Don’t forget to join BioCanRx’s free series of interesting and interactive virtual talks on Wednesday, January 13, 2021, 1:45 – 3:15pm EST.
Topic: A randomized phase III trial of vaccination with IMM-101 versus observation for the prevention of severe Covid-19 related infections in cancer patients at increased risk of exposure.
Each speaker session will include a plain language overview and wrap up, with an opportunity for questions.
- Dr. Rebecca Auer – Ottawa Hospital Research Institute, The Ottawa Hospital, University of Ottawa
- Dr. Chris O’Callaghan – Canadian Cancer Trials Group
- Judy Needham – Patient Perspective & Plain Language Summary